Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

391
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
391
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

551
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
551
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

566
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
566
Hazard Rate01:11

Hazard Rate

400
The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
400
Actuarial Approach01:20

Actuarial Approach

286
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
286
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

745
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
745

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Photoelectrochemically homogeneous nickel oxide photocathode composed of nanocrystals prepared by supercritical hydrothermal synthesis.

Nanoscale advances·2026
Same author

Coexistence of Metal and Dielectric Resonance Modes in a Single Nanostructure of a Hyperbolic Material.

ACS nano·2026
Same author

Plant-derived exosome-like nanoparticles ameliorate glycolipid metabolism diseases: molecular mechanism, advances and bottlenecks.

Food & function·2026
Same author

Privacy-enhancing sequential learning under heterogeneous selection bias in multi-site electronic health records data.

Journal of the American Medical Informatics Association : JAMIA·2026
Same author

Phase Ib/II Study of Preliminary Efficacy, Safety and Pharmacodynamics of MG-K10, a Humanised Monoclonal Antibody Targeting IL-4Rα, in Adult Chinese Patients With Asthma.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026
Same author

Longitudinal analyses of depressive symptoms across pregnancy in Black women.

Annals of epidemiology·2026
Same journal

A Causal Framework for Evaluating the Total Effect of Strategies Aiming to Expand Screening and to Improve Outcomes.

Statistics in medicine·2026
Same journal

Causal Effects on Nonterminal Event Time With Application to Antibiotic Usage and Future Resistance.

Statistics in medicine·2026
Same journal

Subgroup Analysis of Interval-censored Failure Time Data With Application to Alzheimer's Disease.

Statistics in medicine·2026
Same journal

Rejoinder to Commentaries on "A Perspective on the Appropriate Implementation of ICH E9(R1) Addendum Strategies for Handling Intercurrent Events".

Statistics in medicine·2026
Same journal

A Multi-Stage Drop-the-Loser Design With Superiority Boundaries.

Statistics in medicine·2026
Same journal

Interpretable ROI Identification in Brain Image Analysis: Overcoming CNN Black Box Challenges With Kriging-Enhanced Adaptive Sampling.

Statistics in medicine·2026
See all related articles

Related Experiment Video

Updated: Jan 14, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

523

Collaborative Inference for Accelerated Failure Time Model Using Clinical Center-Level Summary Statistics.

Mengtong Hu1, Xu Shi1, Ziyang Gong2

  • 1Department of Biostatistics, University of Michigan, Ann Arbor, Michigan, USA.

Statistics in Medicine
|October 22, 2025
PubMed
Summary
This summary is machine-generated.

This study introduces a new framework for analyzing survival data from multi-center clinical trials using the Accelerated Failure Time (AFT) model. This approach enhances data integration and provides more reliable results for time-to-event outcomes.

Keywords:
data privacydistributed inferencemeta‐analysisrenewable estimationsurvival analysis

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.5K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.7K

Related Experiment Videos

Last Updated: Jan 14, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

523
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.5K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.7K

Area of Science:

  • Biostatistics
  • Clinical Research Methodology
  • Survival Analysis

Background:

  • Multi-center clinical research yields larger sample sizes and more generalizable findings.
  • Existing methods for survival data analysis may have limitations in integrative analyses across multiple sites.
  • The Accelerated Failure Time (AFT) model offers an alternative to the Cox proportional hazards model for time-to-event data.

Purpose of the Study:

  • To develop a collaborative analytic framework for survival data analysis using summary statistics.
  • To implement a distributed inference method based on parametric Accelerated Failure Time (AFT) models.
  • To assess the goodness-of-fit for different parametric AFT models using a distributed likelihood ratio test.

Main Methods:

  • Developed a collaborative framework utilizing summary statistics for survival data analysis.
  • Employed parametric AFT models (Weibull, log-normal, log-logistic) for time-to-event outcomes.
  • Established a distributed likelihood ratio test under the generalized gamma distribution for model assessment.

Main Results:

  • The proposed distributed inference method demonstrates robust performance.
  • Large-sample properties of the distributed method were established.
  • The framework was validated through simulations and a real-world kidney transplantation dataset.

Conclusions:

  • The developed framework facilitates flexible and robust integrative analyses of multi-center survival data.
  • The AFT model and distributed inference approach offer advantages over traditional methods for multi-site studies.
  • This methodology enhances the reliability and generalizability of findings from collaborative clinical research.